AlvireX: A game-changing translational drug screening platform to revolutionize drug development against respiratory viral infections - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

53709.1 IP-LS

Project title

AlvireX: A game-changing translational drug screening platform to revolutionize drug development against respiratory viral infections

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Inserted texts

Category	Text
Short description (German)	AlvireX: A game-changing translational drug screening platform to revolutionize drug development against respiratory viral infections
Short description (English)	AlvireX: A game-changing translational drug screening platform to revolutionize drug development against respiratory viral infections
Abstract (German)	The consortium will develop AlvireX - a novel drug screening platform that will accelerate and improve drug development for respiratory viruses, such as SARS-CoV-2. Here, we will deliver the first AlvireX kit tailored to COVID-19 research, which will be ready to enter the market in Q1 2023.